About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Antagonist Protocol in Poor Responders | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 4NCT02195947

Antagonist Protocol in Poor Responders

The effect of use of the growth hormone with antagonist protocol on the outcome of the IVF/ICSI cycles in poor responders.

Lead sponsor: Cairo University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Cairo University

Two groups of poor responder female patients planned to receive the antagonist IVF/ICSI protocol are randomized to whether or not to add growth hormone to their protocol.

Age

20 - 45 years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•females fulfilling the criteria of the ESHRE consensus 2011:
•at least two of the following three features must be present:
•dvanced maternal age (≥40 years) or any other risk factor for POR
•previous POR (≤3 oocytes with a conventional stimulation protocol)
•an abnormal ovarian reserve test (i.e. AFC ,5-7 follicles or AMH ,0.5 -1.1 ng/ml).

Exclusion Criteria

•women who suffer from any other cause of infertility other than poor ovarian reserve
•refusal of the patient to consent for using her data in the study.

Related studies

UNKNOWNPhase 1/2

Effect of Testosterone Treatment on Embryo Quality

NCT01662466 · Primary Ovarian Insufficiency, Female Infertility Due to Diminished Ovarian Reserve

UNKNOWNPhase 1/2

Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF

NCT02179255 · Female Infertility Due to Diminished Ovarian Reserve

COMPLETEDPhase 4

IVF/ICSI Protocols in Poor Responders With Growth Hormone

NCT01897324 · Female Infertility Due to Diminished Ovarian Reserve

COMPLETEDPhase 4

Microflare Protocol in Poor Responders

NCT02185326 · Female Infertility Due to Diminished Ovarian Reserve

Vitamin D Influence on Oocyte Donation

NCT02341365 · Disorder of Phosphate, Calcium and Vitamin D Metabolism, Female Infertility Due to Diminished Ovarian Reserve, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 11, 2021Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment141

Start dateJul 2014

Last updatedNov 11, 2021

Condition

Female Infertility Due to Diminished Ovarian Reserve

Locations shown

Kasr Al Aini

Cairo

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 11, 2021Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions